David Collier

England & Wales Cricket Board Ltd. operates professional sports teams and organizations. The company also operates various charities such as cricket foundation, and programs like building partnerships. England & Wales Cricket Board was founded in 1997 and is headquartered in London, UK.

Predix Pharmaceuticals Holdings, Inc. is a pharmaceutical company focused on the discovery and development of novel, highly selective, small-molecule drugs that target G-Protein Coupled Receptors (GPCRs) and ion channels.

VeraLight, Inc. develops noninvasive technologies for the disease detection and health monitoring of diabetes epidemics. It offers a noninvasive diabetes screening system designed to provide a method for screening pre-diabetes based on the presence of diabetes-related biomarkers found in skin. The company was founded by David Van Avermaete and John Maynard in October 2004 and is headquartered in Albuquerque, NM.

Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA.

Exela Pharma Sciences LLC develops and manufactures generic injectable, ophthalmic and inhalation pharmaceutical products. It offers analytical, formulation, lyophilization cycle development, and manufacturing and microbiology services and also operates a sterile manufacturing facility. The firm transforms product development ideas into clinically safe and effective medicines. It works to bring to the market a number of pharmaceutical products covering multiple therapeutic areas and dosage forms. Exela Pharma Sciences was founded by S.R. Murthy Mallipeddi and Phanesh Koneru in 2005 and is headquartered in Lenoir, NC.

Velocity Pharmaceutical Holdings LLC operates as a holding American company.

Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA.

Vallinex, Inc. provides chronic pain relief products. Its product, VLNX-4975 is used to treat the osteoarthritis and other chronic pain conditions. The company is headquartered in Baltimore, MD.

Reeve Foundation - Presidio Partners NRT LP is a special purpose vehicle formed to invest in NeuroRecovery Technologies Inc.

Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA.

X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA.